Dong Cho Han Selected Research

Dong Cho Han Research Topics

Disease

37	Neoplasms (Cancer) 10/2021 - 04/2003
7	Prostatic Neoplasms (Prostate Cancer) 10/2021 - 01/2009
6	Carcinoma (Carcinomatosis) 03/2021 - 02/2004
3	Colorectal Neoplasms (Colorectal Cancer) 10/2013 - 09/2008
2	Neoplasm Metastasis (Metastasis) 01/2019 - 07/2013
2	Inflammation (Inflammations) 05/2015 - 09/2008
2	Breast Neoplasms (Breast Cancer) 12/2011 - 10/2002
2	Body Weight (Weight, Body) 01/2011 - 10/2003
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2018
1	Colonic Neoplasms (Colon Cancer) 10/2017
1	Diabetes Mellitus 12/2016
1	Fibrosarcoma 06/2007
1	Embryonal Carcinoma 11/2002

Drug/Important Bio-Agent (IBA)

9	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2021 - 01/2009
9	Proteins (Proteins, Gene)FDA Link 06/2021 - 10/2002
7	Pharmaceutical PreparationsIBA 10/2021 - 02/2004
5	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2021 - 02/2004
5	TransferasesIBA 04/2006 - 04/2003
4	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 01/2006
3	Biological ProductsIBA 12/2016 - 10/2002
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2013 - 01/2012
3	2'-benzoyloxycinnamaldehydeIBA 01/2009 - 02/2004
2	N2- (1H- indazole- 5- yl)- N6- methyl- 3- nitropyridine- 2,6- diamineIBA 06/2021 - 01/2011
2	methyllucidoneIBA 01/2018 - 11/2005
2	Protein Tyrosine PhosphatasesIBA 01/2018 - 08/2012
2	SurvivinIBA 10/2017 - 04/2015
2	Cyclin D1IBA 10/2017 - 10/2002
2	Cyclin AIBA 10/2017 - 10/2002
2	ginkgetinIBA 10/2017 - 04/2015
2	Caspase 3 (Caspase-3)IBA 05/2015 - 11/2005
2	5- (5- ethyl- 2- hydroxy- 4- methoxyphenyl)- 4- (4- methoxyphenyl)isoxazoleIBA 01/2008 - 12/2005
1	flavoneIBA 10/2021
1	acacetinIBA 10/2021
1	xanthatinIBA 03/2021
1	Antitussive Agents (Antitussives)FDA Link 01/2019
1	benproperineIBA 01/2019
1	Actin-Related Protein 2-3 Complex (Arp2 3 Complex)IBA 01/2019
1	Pyruvate KinaseIBA 10/2018
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2018
1	Transcription Factor 4IBA 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	piperlongumineIBA 01/2018
1	TransketolaseIBA 09/2015
1	sugiolIBA 09/2015
1	CarcinogensIBA 06/2015
1	fisetinIBA 06/2015
1	FlavonoidsIBA 06/2015
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2015
1	LuciferasesIBA 06/2015
1	Transcription Factors (Transcription Factor)IBA 06/2015
1	dihydrochalconeIBA 05/2015
1	Cantharidin (Cantharides)IBA 10/2013
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 10/2013
1	RhodanineIBA 07/2013
1	Emodin (Archin)IBA 01/2012
1	cosmomycin CIBA 12/2011
1	CurcuminIBA 01/2011
1	MetallothioneinIBA 01/2009
1	cryptotanshinoneIBA 01/2009
1	LignansIBA 09/2008
1	magnololIBA 09/2008
1	obovatolIBA 09/2008
1	honokiolIBA 09/2008
1	Hydroxylamine (Hydroxylamine Hydrochloride)IBA 10/2007
1	Proteasome InhibitorsIBA 08/2007
1	obovatalIBA 06/2007
1	Matrix Metalloproteinases (MMPs)IBA 06/2007
1	EnzymesIBA 06/2007
1	Dihydrotachysterol (AT 10)IBA 04/2006
1	dehydrotrametenolic acidIBA 01/2006
1	diphenyl (biphenyl)IBA 12/2005
1	Small Interfering RNA (siRNA)IBA 12/2005
1	IsoxazolesIBA 12/2005
1	Protein Kinase CIBA 12/2005
1	phorbolIBA 12/2005
1	AbietanesIBA 04/2005
1	arteminolide CIBA 10/2003
1	Cyclin B1IBA 04/2003
1	Immunologic Factors (Immunomodulators)IBA 04/2003
1	cinnamaldehyde (cinnamic aldehyde)FDA Link 04/2003
1	Cytostatic AgentsIBA 04/2003
1	LigandsIBA 11/2002
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2002
1	Cyclin EIBA 10/2002
1	sesquicillinIBA 10/2002

Therapy/Procedure

8	Therapeutics 01/2019 - 02/2004
1	Drug Therapy (Chemotherapy) 05/2016